期刊文献+

HBx参与肝细胞癌发生发展调控的分子机制 被引量:3

The Role of HBx in Regulating the Genesis of Hepatocellular Carcinoma
下载PDF
导出
摘要 肝细胞癌(hepatocellular carcinoma,HCC)是我国最常见的恶性肿瘤之一,而HBV慢性感染是肝癌发生的主要原因.乙型肝炎病毒(HBV)中X基因编码的一种多功能蛋白(HBx),参与众多重要生物学过程的调控,并促进肝细胞癌的发生.早期研究表明,HBx在HCC发生过程中发挥重要的调控功能,但其确切分子机制尚未完全明确.近几年,HBx参与生物学过程的分子机制研究有了较快的进展.有趣的是,研究发现,HBx在不同的细胞系以及HBV感染的不同阶段发挥促抑凋亡的双重作用,HBx还参与细胞自噬的调控.此外,在HBx参与细胞增殖及肿瘤侵袭和转移等方面,也产生了一些新的认识.本文将从HBx对肝细胞凋亡、自噬和增殖的调控及其对肝癌细胞转移和侵袭的调控等方面,对HBx参与肝细胞癌发生发展调控机制做一综述. Hepatocellular carcinoma (HCC) is one of the most common cancers in China. The chronicinfection of HBV is one of the main causes of HCC. A muhifunctional protein (HBx) encoded by the X gene of hepatitis B virus (HBV), is involved in a variety of biological processes and can promote the genesis of HCC. Although HBx has been known as an important regulatory protein during the genesis of HCC, but the detailed molecular mechanism is not clear completely. In recent years, there have been significant advancements in the molecular mechanisms for HBx promoting HCC. Interestingly, HBx can promote and inhibit apoptosis at different cell line or different stages of HBV infection. To understand this important issue, this review describes the new insights about HBx related HCC driver genes, therapy targets, and the molecular mechanisms for three basic cellular processes, including apoptosis/autophagy, cell proliferation and tumor metastasis/invasion
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2013年第8期704-710,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家重点基础研究发展计划(No.2011CB910601) 国家自然科学基金(No.81000192)资助项目~~
关键词 X基因编码的HBx蛋白(HBx) 肝细胞癌(HCC) 信号转导 DNA复制 细胞凋亡 hepatitis B virus X protein (HBx) hepatocellular carcinoma(HCC) signal transduction DNA duplication apoptosis
  • 相关文献

参考文献55

  • 1Kew M C. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-indued hepatocellular carcinoma[J] .J Gastroenterol Hepatol, 2011, 26 (Suppl I) : 144-152.
  • 2Balsano C, Avantaggiati M L, Natoli G, et al. Full-length and truncated versions of the hepatitis B virus (HBV) X protein ( pX) transactivate the cmyc protooncogene at the transcriptional level[J]. Biochem Biophys Res Commun, 1991, 176 (3) : 985- 992.
  • 3Chirillo P, Falco M, Puri P L, et al. Hepatitis B virus pX activates NF -kappa B-dependent transcription through a Raf?independent pathway[J].J Virol, 1996,70(1): 641-646.
  • 4Choi B H, Park G T, Rho H M. Interaction of hepatitis B viral X protein and CCAATI enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II I pregenomic promoter[J].J Bioi Chern, 1999,274(5): 2858- 2865.
  • 5Kim H R, Lee S H,Jung G. The hepatitis B viral X protein activates NF -kappaB signaling pathway through the up-regulation of TBKI[J]. FEBS Lett, 2010, 584( 3) : 525-530.
  • 6Tanaka Y, Kanai F, Ichimura T, et al. The hepatitis B virus X protein enhances AP-I activation through interaction withJahl l r l Oncogene, 2006, 25 (4) : 633 -642.
  • 7TwuJ S, Lai MY, Chen D S, et al. Activation of protooncogene c-jun by the X protein of hepatitis B virus[J]. Virology, 1993, 192 ( I ) : 346-350.
  • 8JungJ K, Park S H,Jang K L. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation[J].J Gen Virol, 2010, 91(Pt2): 493-500.
  • 9LeeJ 0, Kwun HJ,JungJ K, et al. Hepatitis B virus X protein represses Evcedberin expression via activation of DNA methyltransferase I[J]. Oncogene, 2005, 24(44): 6617-6625.
  • 10Zhu Y Z, Zhu R, FanJ, et al. Hepatitis B virus X protein induces hypermethylation of pl6 ( INK4A) promoter via DNA methyltransferases in the early stage of HBV -associated hepatocarcinogenesis[J].J Viral Hepat, 2010, 17(2): 98-107.

二级参考文献33

  • 1Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochmnic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [ J]. Cell, 1993,75 (5) : 843-854.
  • 2Bala S, Petrasek J, Mundkur S, et al. Circulating mieroRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced and inflammatory liver diseases [ J ]. Hepatology,2012, doi: 10. 1002/hep. 25873.
  • 3Buhler S, Bartenschlager R. New targets for antiviral therapy of chronic hepatitis C[J]. Liver Int,2012,32Supp11:9-16.
  • 4Gandellini P, Profumo V, Folini M, et al. MicroRNAs as new therapeutic targets and tools in cancer [ J ]. Expert Opin Ther Targets, 2011,15(3) : 265-279.
  • 5Selbach M, Sehwanhausser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by mieroRNAs[ J]. Nature, 2008,455(7209) : 58-63.
  • 6Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse [ J ]. Curr Biol,2002,12 (9) : 735-739.
  • 7Girard M, Jacquemin E, Munnich A, et al. miR-122, a paradigm for the role of microRNAs in the liver[ J]. J Hepatol, 2008,48(4) : 648-656.
  • 8Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases[J]. Clin Chem,2010,56(12) : 1830-1838.
  • 9Tang Y, Banan A, Forsyth C B, et al. Effect of alcohol on miR- 212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease [ J ]. Alcohol Clin Exp Res, 2008,32 (2) : 355-364.
  • 10Miranda R C, Pietrzykowski A Z, Tang Y, et al. MicroRNAs: master regulators of ethanol abuse and toxicity? [ J ]. Alcohol Clin Exp Res,2010,34(4) : 575-587.

共引文献7

同被引文献35

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部